News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.
Mounjaro has become popular as a weight loss drug but it also seems to be linked to hair loss in some cases in a worrying new ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
W. Timothy Garvey, M.D., served as lead author in the clinical trial. A new combination drug therapy is showing extraordinary ...
The weight loss and diabetes drug, which is only available on prescription, should be on pharmacy shelves within days ending ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...
GPs across England will, for the first time, be able to prescribe a new weight loss injection on the NHS from Monday, as the ...